tamsulosin and digoxin
tamsulosin has been researched along with digoxin in 8 studies
Compound Research Comparison
| Studies (tamsulosin) | Trials (tamsulosin) | Recent Studies (post-2010) (tamsulosin) | Studies (digoxin) | Trials (digoxin) | Recent Studies (post-2010) (digoxin) |
|---|---|---|---|---|---|
| 1,460 | 468 | 693 | 11,483 | 958 | 1,289 |
Protein Interaction Comparison
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Li Wan Po, A | 1 |
| Forrest, A; Ito, Y; Kamimura, H; Miyazawa, Y; Paul Starkey, L; Schentag, JJ; Swarz, H | 1 |
Reviews
1 review(s) available for tamsulosin and digoxin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Trials
1 trial(s) available for tamsulosin and digoxin
| Article | Year |
|---|---|
Effects of the concomitant administration of tamsulosin (0.8 mg) on the pharmacokinetic and safety profile of intravenous digoxin (Lanoxin) in normal healthy subjects: a placebo-controlled evaluation.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Anti-Arrhythmia Agents; Digoxin; Dizziness; Female; Humans; Infusions, Intravenous; Male; Placebos; Sulfonamides; Tamsulosin | 2002 |
Other Studies
6 other study(ies) available for tamsulosin and digoxin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Digoxin-drug interactions: study design and generalizability.
Topics: Adrenergic alpha-Antagonists; Anti-Arrhythmia Agents; Anti-Infective Agents; Bias; Digoxin; Drug Interactions; Health Status; Humans; Ofloxacin; Patient Selection; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Sulfonamides; Tamsulosin | 2002 |